Myeloma of the Central Nervous System: Strong Association with Unfavorable Chromosomal Abnormalities and Other High-risk Disease Features

References

• Hallek, M., Bergsagel, P.L. and Anderson, K.C. (1998) "Multiple myeloma: increasing evidence for a multistep transformation process", Blood, 91, 3–21.
   Google Scholar
• Brenner, B., Carter, A., Tatarsky, I., Gruszkiewicz, J. and Peyser, E. (1982) "Incidence, prognostic significance and therapeutic modal-ities of central nervous system involvement in multiple myeloma", Acta Haematologica, 68, 77–83.
   Google Scholar
• Fassas, A.B-T., Muwalla F., Berryman, T., Benramdane, R., Joseph, L., Anaissie, E., et al. (2001) "Myeloma of the central nervous system: association with high-risk chromosomal abnorm-alities, plasmablastic morphology and extramedullary manifesta-tions", Britsih Journal of Haematology, 117, 103 — 108.
   Google Scholar
• Petersen, S.L., Wagner, A. and Gimsing, P. (1999) "Cerebral and meningeal multiple myeloma after autologous stem cell transplanta-tion. A case report and review of the literature", American Journal of Hematology, 62, 228–233.
   Google Scholar
• Maghfoor, I. and Perry, M.C. (2000) "Meningeal myeloma: A case report and review of literature", Hematology, 5, 47— 52.
   Google Scholar
• Patriarca, F., Zaja, F., Sivestri, F., Sperotto, A., Scalise, A., Gigli, G., et al. (2001) "Meningeal and cerebral involvement in multiple myeloma patients", Annals of Hematology, 80, 758–762.
   Google Scholar
• Ochiai, N., Shimazaki. C., Okano, A., Hatsuse, M., Takahashi, R., Hirai, H., et al. (2002) "Meningeal relapse after double peripheral blood stem cell transplantation in IgD myeloma", Leukemia and Lymphoma, 43, 641 — 643
   Google Scholar
• Dennis, M. and Chu, P. (2000) "A case of meningeal myeloma presenting as obstructive hydrocephalus—a therapeutic challenge", Leukemia and Lymphoma, 40, 219–220.
   Web of Science ®Google Scholar
• Sekikawa, T., Iwase, S., Kawano, T., Takahara, S., Ito, K., Yamada, J., et al. (1999) "[A case of aggressive myeloma with abnormal plasmacytes in pleural effusion and cerebrospinal fluid]", Rinsho Ketsueki, 40, 22–27.
   Google Scholar
• Ulusakarya, A., Youssef, A., Bayle, C., Vantelon, J.M. and Munck, J.N. (1999) "Plasma cell meningitis after an autograft in a patient with multiple myeloma", Leukemia and Lymphoma, 34, 633–634.
   Google Scholar
• Savage, D.G., Mears, J.G., Balmaceda, C., Rescigno, J., Shendrik, I., Mansukhani, M., et al. (2002) "Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation", Leukemia and Research 26, 689–692.
   PubMed Web of Science ®Google Scholar
• Kornberg, A., Voltchek, J. and Hardan, I. (2000) "Central nervous system relapse in multiple myeloma in systemic remission after autologous stem cell transplantation", American Society of Hema-tology, 347h (abstract 5254).
   Google Scholar
• Calavia, J., Loyola, I., Richard, C., Baro, J., Recio, M., Cuadrado, M.A., et al. (1993) "[Intial central nervous system involvement in a case of non-secretory multiple myeloma]", Sangre, 38, 389–391.
   Google Scholar
• Hayakawa, H., Obama, K. and Tara, M. (2002) "[Intradural recurrence of multiple myeloma during the hematological complete remission]", Rinsho Ketsueki 43, 1009— 1013.
   Google Scholar
• Schluterman, K., Fassas, A., Van Hemert, R. and Hank, S. Multiple myeloma invasion of the central nervous system. Brain (submitted).
   Google Scholar
• Barlogie, B., Jagganath, S., Vesole, D.H., Naucke, S., Mattox, S., Bracy, D., et al. (1997) "Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma", Blood, 89, 789–793.
   Google Scholar
• Barlogie, B., Jagannath, S., Desikan, K.R., Mattox, S., Vesole, D., Siegel, D., et al. (1999) "Total therapy with tandem transplants for newly diagnosed multiple myeloma", Blood, 93, 55–65.
   Google Scholar
• Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., et al. (1999) "Antitumor activity of thalidomide in refractory multiple myeloma", New England Journal of Medicine, 18, 1565 — 1571.
   Google Scholar
• Fassas, A. B-T., Spencer, T., Sawyer, J., Zangari, M., Lee, C-K., Anaissie, E., et al. (2002) "Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma", British Journal of Haematology, 118, 1041–1047.
   PubMed Web of Science ®Google Scholar
• Tricot, G., Sawyer, J., Jagannath, S., Desikan, KR., Siegel, D., Naucke, S., Mattox, S., et al. (1997) "Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants", Journal of Clinical Oncology, 15, 2659–2666.
   Google Scholar
• Greipp, P.R., Leong, T., Bennett, J., Gaillard, J.P., Klein, B., Stewart, J.A., et al. (1998) "Plasmablastic morphology: an independent prognostic factor with clinical and laboratory corre-lates: Eastern Cooperative Oncology Group (ECOG) Myeloma trial E9486 report by the ECOG Myeloma Laboratory Group", Blood, 91, 2501 — 2507.
   Google Scholar
• Dimopoulos, M.A., Barlogie, B., Smith, T.L. and Alexanian, R. (1991) "High serum lactate dehydrogenase level as a marker for drug resistance and short survival multiple myeloma", Annals of Internal Medicine, 115, 931 — 935.
   Google Scholar
• Barlogie, B., Smallwood, L., Smith, T., and Alexanian, R. (1989) "High serum levels of lactic dehydrogenase identify a high-grade lymphoma type myeloma", Annals of Internal Medicine, 110, 521 — 525.
   Google Scholar
• Fassas, A.B-T., Van Rhee, F. and Tricot, G. (2003) "Predicting long-term survival in multiple myeloma patients following auto-transplants", Leukemia and Lymphoma, 44, 749–758.
   Web of Science ®Google Scholar
• Tricot, G., Vesole, D., Jagannath, S., Hilton, J., Munshi, N. and Barlogie, B. (1996) "Graft-versus-myeloma effect: proof of princi-ple", Blood, 87, 1196–1198.
   Google Scholar
• Price R.A. and Johnson, W.W. (1973) "The central nervous system in childhood leukemia. I. The arachnoid", Cancer, 31, 520— 533.
   Google Scholar
• Leifer, D., Grabowski, T., Simonian, N., and Demirjian, Z. (1992) "Leptomeningeal myelomatosis presenting with mental status changes and other neurologic findings", Cancer 70, 1899–1904.
   PubMed Web of Science ®Google Scholar
• De Blay, V., Misson, N., Dardenne, G and Dupuis, M.J. (2000) "Leptomeningeal myelomatosis mimicking a subdural haemato-ma", Neuroradiology, 42, 735–737.
   PubMed Web of Science ®Google Scholar
• Roddie, R., Collie, D. and Johnson, P. (2000) "Myelomatous involvement of the dura mater: a rare complication of multiple myeloma", Journal of Clinical Pathology, 53, 398 — 399.
   Google Scholar
• Dahl, LM., Rasmussen, T., Kauric G. and Husebekk, A. (2002) "Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma", British Journal of Haematology, 116, 273— 277.
   Google Scholar
• Sahara N., Takeshita, A., Shigeno, K., Fujisawa S., Takeshita, K., Naito, K., et al. (2002) "Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma", Britsh Journal of Haematology, 117, 882–885.
   PubMed Web of Science ®Google Scholar
• Schwartz, T.H., Rhiew R., Isaacson, SR., Orazi, A. and Bruce, J.N. (2001) "Association between intracranial plasmacytoma and multi-ple myeloma: clinicopathological outcome study", Neurosurgery, 49, 1039–1045.
   Google Scholar
• Badros, A., Barlogie, B., Morris, C., Desikan, R., Martin, SR., Munshi, N., et al. (2001) "High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions", Blood, 97, 2574–2579.
   Google Scholar